These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27133142)

  • 1. Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now.
    Pop-Busui R; Martin C
    Int Rev Neurobiol; 2016; 127():9-25. PubMed ID: 27133142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.
    Pop-Busui R; Herman WH; Feldman EL; Low PA; Martin CL; Cleary PA; Waberski BH; Lachin JM; Albers JW;
    Curr Diab Rep; 2010 Aug; 10(4):276-82. PubMed ID: 20464532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.
    Pop-Busui R; Hotaling J; Braffett BH; Cleary PA; Dunn RL; Martin CL; Jacobson AM; Wessells H; Sarma AV;
    J Urol; 2015 Jun; 193(6):2045-51. PubMed ID: 25584994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
    Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications).
    Pop-Busui R; Cleary PA; Braffett BH; Martin CL; Herman WH; Low PA; Lima JAC; Bluemke DA;
    J Am Coll Cardiol; 2013 Jan; 61(4):447-454. PubMed ID: 23265339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Braffett BH; Gubitosi-Klug RA; Albers JW; Feldman EL; Martin CL; White NH; Orchard TJ; Lopes-Virella M; Lachin JM; Pop-Busui R;
    Diabetes; 2020 May; 69(5):1000-1010. PubMed ID: 32051148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.
    Martin CL; Albers J; Herman WH; Cleary P; Waberski B; Greene DA; Stevens MJ; Feldman EL;
    Diabetes Care; 2006 Feb; 29(2):340-4. PubMed ID: 16443884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Autonomic Neuropathy, Sexual Dysfunction, and Urinary Incontinence in Women With Type 1 Diabetes.
    Hotaling JM; Sarma AV; Patel DP; Braffett BH; Cleary PA; Feldman E; Herman WH; Martin CL; Jacobson AM; Wessells H; Pop-Busui R;
    Diabetes Care; 2016 Sep; 39(9):1587-93. PubMed ID: 27352953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
    Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autonomic dysfunction syndrome and diabetic cardiac autonomic neuropathy in children with diabetes mellitus type I. The correction method].
    Manukian VIu; Bolotova NV; Aver'ianov AP; Filina NIu; Raĭgorodskiĭ IuM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):33-7. PubMed ID: 21350409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.
    Pop-Busui R; Braffett BH; Wessells H; Herman WH; Martin CL; Jacobson AM; Sarma AV
    Diabetes Care; 2022 Jan; 45(1):119-126. PubMed ID: 34728530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data.
    Lagani V; Chiarugi F; Thomson S; Fursse J; Lakasing E; Jones RW; Tsamardinos I
    J Diabetes Complications; 2015; 29(4):479-87. PubMed ID: 25772254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.